Chairman of the board and chief executive officer, Merck & Co., Inc. Director, Exxon Mobil and PhRMA. Member, Board of Overseers, Weill Cornell Medicine. Trustee, Cornerstone Christian Academy. Our director since Jan. 1, 2011.
Chairman and chief executive officer, Sarr Group, LLC (investment holding company). Non-executive chairman, Broadridge Financial Solutions, Inc. and CDK Global, Inc. Director, Hewlett Packard Enterprise Company and NXT Capital, Inc. Our director since July 22, 2008.
Investigator, Howard Hughes Medical Institute. Distinguished Professor, University of Colorado. Director, BioFrontiers Institute, University of Colorado. Our director since May 27, 2009.
President, Google Customer Solutions, Google. Member, Ross School Advisory Board, University of Michigan. Our director since March 18, 2019.
Former chief financial officer, Accenture (global management consulting, technology services and outsourcing company). Director, The Progressive Corporation and 3M Company. Our director since Sept. 1, 2015.
Retired chief executive officer, Thomson Reuters Corporation (information and services company for businesses and professionals). Founder and managing partner, Angelic Ventures, L.P. Director, Morgan Stanley. Member, Supervisory Board, Publicis Groupe. Our director since Nov. 27, 2007.
Penn Integrates Knowledge Professor of Health Equity and Health Policy, University of Pennsylvania. President Emerita, Robert Wood Johnson Foundation. Our director since May 26, 2020.
Dean of medical faculty and vice president for medicine, The Johns Hopkins University, and CEO, Johns Hopkins Medicine. Our director since Sept. 1, 2015.
Chairman, Hewlett Packard Enterprise Company. Former chief executive officer and director, Alcatel-Lucent. Director, General Motors Company and KKR Management LLC (managing partner KKR & Co., L.P.). Our director since Sept. 1, 1995.
Thomas W. Smith Professor of Medicine and Genetics, Harvard Medical School and Director, Cardiovascular Genetics Center, Brigham and Women’s Hospital. Investigator, Howard Hughes Medical Institute. Our director since March 16, 2020.
Former chairman of the board, president and chief executive officer, 3M Company. Our director since March 1, 2018.
Chairman, chief executive officer and president, Northrop Grumman Corporation. Director, Northrop Grumman Corporation. Our director since March 16, 2020.
Managing director, Sierra Ventures (technology-oriented venture capital firm). Faculty, Stanford University Graduate School of Business. Senior advisor and director, WestBridge Crossover Fund, LLC. Our director since Sept. 23, 2003.
Dates prior to the merger of Merck & Co., Inc. ("Merck") and Schering-Plough Corporation ("Schering-Plough") on November 3, 2009, reflect membership on the board of legacy Merck (Brun, Cech, Glocer and Wendell) or legacy Schering-Plough (Russo), as the case may be.
Our code of conduct reflects our corporate values and guides our day-to-day decision making.